nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—HRH2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0668	0.0668	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0562	0.0562	CbGpPWpGaD
Methantheline—HRH2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0541	0.0541	CbGpPWpGaD
Methantheline—HRH2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0455	0.0455	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0341	0.0341	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0326	0.0326	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0301	0.0301	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0274	0.0274	CbGpPWpGaD
Methantheline—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0264	0.0264	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.0232	0.0232	CbGpPWpGaD
Methantheline—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0222	0.0222	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0206	0.0206	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0201	0.0201	CbGpPWpGaD
Methantheline—HRH2—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.0188	0.0188	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0166	0.0166	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.0152	0.0152	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0143	0.0143	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0133	0.0133	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0129	0.0129	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0123	0.0123	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0123	0.0123	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0114	0.0114	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.011	0.011	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.011	0.011	CbGpPWpGaD
Methantheline—HRH2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0104	0.0104	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00976	0.00976	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00943	0.00943	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00934	0.00934	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00934	0.00934	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00895	0.00895	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00869	0.00869	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00841	0.00841	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00805	0.00805	CbGpPWpGaD
Methantheline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00791	0.00791	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00718	0.00718	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00699	0.00699	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00695	0.00695	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00682	0.00682	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00664	0.00664	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00649	0.00649	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00629	0.00629	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00622	0.00622	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00614	0.00614	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00598	0.00598	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00598	0.00598	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00556	0.00556	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00539	0.00539	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00537	0.00537	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00528	0.00528	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00528	0.00528	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0051	0.0051	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00506	0.00506	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00493	0.00493	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00491	0.00491	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00489	0.00489	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00479	0.00479	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00479	0.00479	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00475	0.00475	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0046	0.0046	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00456	0.00456	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00456	0.00456	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00446	0.00446	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00437	0.00437	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00437	0.00437	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00432	0.00432	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00424	0.00424	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0041	0.0041	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00407	0.00407	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00406	0.00406	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00385	0.00385	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00369	0.00369	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0035	0.0035	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0035	0.0035	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00332	0.00332	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00324	0.00324	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00319	0.00319	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00304	0.00304	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00299	0.00299	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00286	0.00286	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00283	0.00283	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00283	0.00283	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00279	0.00279	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00272	0.00272	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00263	0.00263	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00259	0.00259	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00258	0.00258	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00258	0.00258	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00255	0.00255	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00247	0.00247	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00239	0.00239	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00234	0.00234	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00234	0.00234	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00232	0.00232	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00218	0.00218	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00217	0.00217	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00211	0.00211	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00208	0.00208	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00207	0.00207	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00198	0.00198	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00188	0.00188	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.0018	0.0018	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.0018	0.0018	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00178	0.00178	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00171	0.00171	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.0016	0.0016	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00156	0.00156	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	0.00153	0.00153	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00146	0.00146	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00139	0.00139	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00138	0.00138	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00138	0.00138	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00132	0.00132	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00128	0.00128	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00127	0.00127	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00124	0.00124	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00123	0.00123	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00106	0.00106	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00106	0.00106	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00101	0.00101	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000878	0.000878	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000866	0.000866	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000782	0.000782	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000748	0.000748	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000729	0.000729	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000602	0.000602	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000519	0.000519	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000356	0.000356	CbGpPWpGaD
